About LYFIX
AlphaCentric LifeSci Healthcare Fund Class I is a mutual fund focused on delivering long-term capital appreciation by investing primarily in the healthcare and life sciences sector. The fund allocates at least 80% of its net assets—plus borrowings—toward equities within the expansive healthcare industry, spanning large, mid, and small capitalization companies. Its portfolio is heavily weighted toward leading healthcare names, including major pharmaceuticals, biotechnology firms, healthcare equipment manufacturers, and managed care providers. Notable holdings feature industry leaders such as Eli Lilly and Co, UnitedHealth Group, Johnson & Johnson, and AbbVie, reflecting a blend of growth and value investment styles. The fund is characterized by a relatively high portfolio turnover, indicative of active management, and carries an expense ratio that places it among the higher-cost funds in its category. With a focus exclusively on healthcare, AlphaCentric LifeSci Healthcare Fund Class I offers investors targeted exposure to a sector that plays a vital role in both the global economy and advancements in medical technology and services.
Fund Family AlphaCentric Funds
Category Health
Performance Rating Average
Risk Rating Above Average
Stock Exchange Nasdaq
Ticker Symbol LYFIX
Share Class Class I
Index S&P 500 TR
LYFIX had a total return of 22.78% in the past year, including dividends. Since the fund's
inception, the average annual return has been 12.45%.
